Cite

HARVARD Citation

    Siva, S. et al. (n.d.). OC-0277 Interim safety analysis of RAPPORT trial - SABR with pembrolizumab in oligometastatic RCC. Radiotherapy and oncology. pp. S137-. [Online]. 
  
Back to record